Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT06966024
Recruiting
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Phase 1 · United States · 8 sites
Registry update: 18 Aug 2026
NCT07928167
Recruiting
Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer Patients
Phase 2 · Russia · 8 sites
Registry update: 10 Nov 2026
NCT07555210
Recruiting
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Not applicable · United States · 1 site
Registry update: 6 May 2026
NCT06910657
Recruiting
IDOV-Immune for Advanced Solid Tumors
Phase 1 · Australia, United States · 5 sites
Registry update: 5 Aug 2026
NCT06479811
Recruiting
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Phase 1 · United States · 1 site
Registry update: 6 Oct 2026
NCT06866262
Recruiting
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
Phase 1/2 · United States · 1 site
Registry update: 31 Jul 2026
NCT07050771
Recruiting
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Phase 2 · United States · 1 site
Registry update: 12 Mar 2026
NCT07118813
Recruiting
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Not applicable · China · 1 site
Registry update: 12 Aug 2025
NCT07172386
Recruiting
Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC
Phase 2 · China · 1 site
Registry update: 16 Sept 2025
NCT07115043
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/2 · Australia, Japan, South Korea, United States · 10 sites
Registry update: 8 Oct 2026
NCT06962787
Recruiting
A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
Phase 2 · China · 1 site
Registry update: 17 Nov 2025
NCT07190638
Recruiting
Comparison of Outcomes and Surgical Time Between Cortical and Medullary Suture vs. Medullary-Only Suture: Cortex Clinical Trial
Not applicable · Brazil · 2 sites
Registry update: 24 Sept 2025
NCT06967961
Recruiting
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Not applicable · France · 1 site
Registry update: 15 Jun 2026
NCT07088536
Recruiting
Occupational Situation and Return to Work of Urological Patients
Not applicable · Poland · 1 site
Registry update: 3 Mar 2026
NCT07049926
Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Phase 1/2 · Chile, Spain, France, United Kingdom, Israel, South Korea, Poland, United States · 33 sites
Registry update: 27 Oct 2026
NCT07386158
Recruiting
Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
Phase 2 · China · 1 site
Registry update: 4 Feb 2026
NCT07097935
Recruiting
Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Phase 1/2 · China · 1 site
Registry update: 1 Aug 2025
NCT06642220
Recruiting
Ablative Radioembolization of Renal Cell Carcinoma Trial
Phase 2 · Canada · 1 site
Registry update: 20 Jul 2025
2024-517789-41-00
Recruiting
CLINICAL AND HUMORAL IMPACT OF PRIMARY TUMOR ABLATION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH IMMUNOTHERAPY.THE ITALIC-RCC RANDOMIZED STUDY
Phase 4 · Italy · 33 sites
Registry update: 17 Nov 2025
NCT06942104
Recruiting
Imaging of Solid Tumors Using 18F-TRX
Phase 1 · United States · 1 site
Registry update: 23 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.